Toxicities of CMV preemptive therapy in the first 100 days after allogeneic hematopoietic cell transplantation (HCT): A real-world study at Memorial Sloan Kettering Cancer Center (MSKCC) Meeting Abstract

  

Authors:	Zavras, P. D.; Su, Y.; Gupta, N.; Maloy, M. A.; Fang, J.; Perales, M. A.; Giralt, S. A.; Jakubowski, A. A.; Papanicolaou, G. A.
Abstract Title:	Toxicities of CMV preemptive therapy in the first 100 days after allogeneic hematopoietic cell transplantation (HCT): A real-world study at Memorial Sloan Kettering Cancer Center (MSKCC)
Meeting Title:	2019 TCT Meetings of ASBMT and CIBMTR
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	25
Issue:	3 Suppl.
Meeting Dates:	2019 Feb 20-24
Meeting Location:	Houston, TX
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2019-03-01
Start Page:	S371
Language:	English
ACCESSION:	WOS:000540655500565
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2018.12.601
Notes:	Meeting Abstract: 557 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/174104